Indications and prescription of hepatitis A vaccine in Spain. Report of the Spanish Association for the Study of the Liver
Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.D.; Ruiz Estremera, A.
Medicina Clinica 111(9): 341-346
1998
ISSN/ISBN: 0025-7753 PMID: 9810537 Document Number: 485950
Document emailed within 1 workday
Related Documents
Bruguera, M.; Buti, M.; Diago, M.; García Bengoechea, M.; Jara, P.; Pedreira, J.A.; Ruiz Extremera, A. 1997: Indications and prescription of hepatitis A vaccine in Spain. Report of the Spain Association for the Study of the Liver Gastroenterologia y Hepatologia 20(9): 467-473Cerezo Pancorbo, J.M.; García Muñoz, M.T.; Sanchez Badia, J.L. 1990: Hepatitis B vaccine: a challenge for Spain Anales Espanoles de Pediatria 32(4): 375-376
Soriano, V.; Gutiérrez, M.; Tuset, C.; Martínez-Zapico, R.; Ortiz de Lejarazu, R.; Aguilera, A.; Codina, G.; González, A.; Ulloa, F.; Leal, M. 1993: A multicenter study of infection with human immunodeficiency virus type-2 (HIV-2) in Spain (1991). the Spanish Group for the Study of HIV-2 Medicina Clinica 100(14): 531-535
Iribarren, J.A.; Ramos, J.T.; Guerra, L.; Coll, O.; de José, M.I.; Domingo, P.; Fortuny, C.; Miralles, P.; Parras, F.; Peña, J.M.; Rodrigo, C.; Vidal, R. 2001: Prevention of vertical transmission and treatment of infection caused by the human immunodeficiency virus in the pregnant woman. Recommendations of the Study Group for AIDS, Infectious Diseases, and Clinical Microbiology, the Spanish Pediatric Association, the National AIDS Plan and the Spanish Gynecology and Obstetrics Society Enfermedades Infecciosas Y Microbiologia Clinica 19(7): 314-335
Cortés, X.; Soriano, J.B.; Sánchez-Ramos, J.L.; Azofra, J.; Almar, E.; Ramos, J. 1998: European study of asthma. Prevalence of atopy in young adults of 5 areas in Spain. Spanish Group of European Asthma Study Medicina Clinica 111(15): 573-577
Corbella, E.; Garghetti, L.; Poloniato, A.; Zambelloni, C.; Consonni, A. 1987: Long-term immunogenicity of hepatitis B vaccine in the neonate and children at risk: antibody levels and indications for booster doses Minerva Pediatrica 39(20): 821-826
Liu, K.Z. 1989: A preliminary study on response to hepatitis B vaccine in subjects with various levels of antibody to hepatitis B surface antigen Zhonghua Yu Fang Yi Xue Za Zhi 23(3): 132-134
Pyshkin, S.A.; Malyshev, I.I.; Dimov, P.G. 1986: Indications for surgical treatment of chronic hepatitis and cirrhosis of the liver Klinicheskaia Khirurgiia 9: 29-32
Yuan, C.D. 1989: Immune response and reactions to simultaneous administration of hepatitis B vaccine with routine vaccine in children. II. Immune response and reactions to simultaneous administration of hepatitis B vaccine with Japanese B encephalitis vaccine and measles vaccine Zhonghua Liu Xing Bing Xue Za Zhi 10(4): 210-214
Camarasa, J.M. 1979: First epidemiological study of contact dermatitis in Spain - 1977. Spanish Contact Dermatitis Research Group Acta Dermato-Venereologica. Suppl 59(85): 33-37
Suárez, C.; Cucala, M.; Coca, A.; Ruilope, L.M. 1999: Spanish contribution to the HOT (Hypertension Optimal Treatment) study. Final results. Spanish Investigators in the HOT study Medicina Clinica 113(10): 361-365
Chen, Y.; Yang, N.; Hong, Y. 1996: Construction of gene library of attenuated liver hepatitis A vaccine (H2 strain) Zhonghua Yi Xue Za Zhi 76(5): 342-344
Singal, A.K. 2009: Hepatitis a vaccine is not required in adult patients with chronic liver disease in Saudi Arabia Singapore Medical Journal 50(4): 442-443
Kukla, Mł.; Gabriel, A.; Sabat, D.; Liszka, Łukasz.; Wilk, M.; Petelenz, Mł.; Musialik, J.; Dzindziora-Frelich, I. 2010: Association between liver steatosis and angiogenesis in chronic hepatitis C Polish journal of pathology: official journal of the Polish Society of Pathologists 61(3): 154-160
Rabo, E. 2003: The "Help to Spain" field hospital during the Spanish Civil War. Swedish-Norwegian contribution for democracy Lakartidningen 100(44): 3522-3525
Armignacco, O.; Andreoni, M.; Sagnelli, E.; Puoti, M.; Bruno, R.; Gaeta, G.Battista.; Perno, C.F.; Santantonio, T.A.; Bonfanti, P.; Bonora, S.; Borderi, M.; Castagna, A.; d'Arminio Monforte, A.; De Luca, A.; Grossi, P.; Guaraldi, G.; Maggiolo, F.; Mussini, C.; Sagnelli, C.; Tavio, M.; Torti, C.; Uberti-Foppa, C.; Andreoni, M.; Angarano, G.; Antinori, A.; Armignacco, O.; Carosi, G.; Chirianni, A.; Di Perri, G.; Galli, M.; Lazzarin, A.; Rizzardini, G.; Sagnelli, E.; Taliani, G. 2014: Recommendations for the use of hepatitis C virus protease inhibitors for the treatment of chronic hepatitis C in HIV-infected persons. A position paper of the Italian Association for the Study of Infectious and Tropical Disease new microbiologica 37(4): 423-438
Nielsen, J.O.; Dietrichson, O.; Juhl, E. 1974: Incidence and meaning of the "e" determinant among hepatitis-B-antigen positive patients with acute and chronic liver diseases. Report from the Copenhagen Hepatitis Acuta Programme Lancet 2(7886): 913-915
Zherebtsov, L.A. 1971: Association of chronic hepatitis and liver cirrhosis with stomach or duodenal ulcers Klinicheskaia Meditsina 49(1): 94-98
Orozco, D.; Gil, V.; Picó, J.A.; Tobías, J.; Quirce, F.; Merino, J. 1995: Diabetes mellitus mortality in Spain: a comparative analysis between Spanish provinces in the period of 1981-1986 Atencion Primaria 15(6): 349-50 352 354-6
1982: Hepatitis B virus vaccine safety: report of an inter-agency group Mmwr. Morbidity and Mortality Weekly Report 31(34): 465-467